Ashley Veldsman
University of Cape Town(ZA)South African Tuberculosis Vaccine Initiative(ZA)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Immune responses and vaccinations, Mycobacterium research and diagnosis, Infectious Diseases and Tuberculosis
Most-Cited Works
- → The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults(2010)227 cited
- → Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells(2009)189 cited
- → Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa(2008)169 cited
- → Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial(2019)134 cited
- → Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial(2020)96 cited
- → T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection(2023)94 cited
- → A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis –infected Adults(2012)86 cited
- → Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants(2011)84 cited
- → MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria(2019)68 cited
- → Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study(2016)58 cited